Mixed‐effects models for slope‐based endpoints in clinical trials of chronic kidney disease

In March of 2018, the National Kidney Foundation, in collaboration with the US Food and Drug Administration and the European Medicines Agency, sponsored a workshop in which surrogate endpoints other than currently established event‐time endpoints for clinical trials in chronic kidney disease (CKD) w...

詳細記述

書誌詳細
主要な著者: Vonesh, E, Tighiouart, H, Ying, J, Heerspink, HL, Lewis, J, Staplin, N, Inker, L, Greene, T
フォーマット: Journal article
言語:English
出版事項: Wiley 2019